The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Order Print Edition


This publication discusses the use of DARZALEX (daratumumab) injection and DARZALEX FASPRO —for the treatment of myeloma.
This booklet discusses dexamethasone, a synthetic steroid that is one of the most frequently used medica­tions in the treatment of myeloma. It can be…

Elrexfio™ (elranatamab-bcmm) is a B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. In August 2023, the U.S. Food and Drug…

This publication discusses the use of Empliciti (elotuzumab)—a monoclonal antibody—for the treatment of myeloma.
This publication discusses how to cope with fatigue caused by anemia and other factors related to the underlying disease.

with support from:

Johnson & Johnson and Pfizer.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.